KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Acquisitions (2017 - 2022)

Historic Acquisitions for Amgen (AMGN) over the last 10 years, with Q4 2022 value amounting to $3.8 billion.

  • Amgen's Acquisitions rose 33134.83% to $3.8 billion in Q4 2022 from the same period last year, while for Dec 2022 it was $4.7 billion, marking a year-over-year increase of 42513.84%. This contributed to the annual value of $27.0 billion for FY2023, which is 60302.16% up from last year.
  • According to the latest figures from Q4 2022, Amgen's Acquisitions is $3.8 billion, which was up 33134.83% from $890.0 million recorded in Q4 2021.
  • In the past 5 years, Amgen's Acquisitions ranged from a high of $13.4 billion in Q4 2019 and a low of -$197.0 million during Q1 2018
  • Moreover, its 4-year median value for Acquisitions was $177.0 million (2019), whereas its average is $2.6 billion.
  • In the last 5 years, Amgen's Acquisitions tumbled by 8947.37% in 2018 and then skyrocketed by 67190000.0% in 2019.
  • Amgen's Acquisitions (Quarter) stood at $2.0 million in 2018, then skyrocketed by 671900.0% to $13.4 billion in 2019, then plummeted by 93.38% to $890.0 million in 2021, then surged by 331.35% to $3.8 billion in 2022.
  • Its last three reported values are $3.8 billion in Q4 2022, $890.0 million for Q4 2021, and $13.0 million during Q3 2021.